BlueSky Wealth Advisors’s Gilead Sciences GILD Stock Holding History

BlueSky Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,267	Closed	-$223K	–	58
2018 Q4	$223K	Hold	3,267	–	–	0.09%	57
2018 Q3	$250K	Hold	3,267	–	–	0.09%	52
2018 Q2	$231K	Hold	3,267	–	–	0.09%	55
2018 Q1	$246K	Sell	3,267 -101	-3%	-$8.03K	0.09%	52
2017 Q4	$241K	Sell	3,368 -48	-1%	-$3.65K	0.1%	51
2017 Q3	$277K	Hold	3,416	–	–	0.12%	51
2017 Q2	$242K	Hold	3,416	–	–	0.11%	50
2017 Q1	$232K	Sell	3,416 -1,471	-30%	-$103K	0.11%	51
2016 Q4	$350K	Buy	+4,887	New	+$363K	0.17%	44

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlueSky Wealth Advisors's GILD Position: Q1 2019 in Review

BlueSky Wealth Advisors sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 3,267 shares — an estimated $223K sold.

BlueSky Wealth Advisors first reported a position in GILD in Q4 2016 and held it in 9 quarters. The position peaked at $350K in Q4 2016. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

BlueSky Wealth Advisors reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
BlueSky Wealth Advisors sold 3,267 Gilead Sciences shares in Q1 2019, an estimated $223K.
BlueSky Wealth Advisors first reported a position in Gilead Sciences in Q4 2016 and held it in 9 quarters.
BlueSky Wealth Advisors's Gilead Sciences position peaked at $350K in Q4 2016.
1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on BlueSky Wealth Advisors's 13F filing for Q1 2019, filed 8 May 2019.